House Approps Approves Bill That Would Give FDA Drug Recall Authority

By Kelly Lienhard / July 9, 2020 at 6:27 PM
House Appropriators on Thursday (July 9) passed out of committee an FDA funding bill that would give the agency authority to mandate the recall of unsafe prescription and over-the-counter drugs. The bill, which would give FDA an increase of $40.8 million over fiscal 2020 funding levels for a total of $3.21 billion in discretionary funding, now heads to the House floor. FDA currently can mandate recalls of medical devices and biologic products, such as vaccines and blood products, but can...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.